The development of specific NOX inhibitors may offer new therapeutic opportunities for fibrotic pathologies.
The discovery of novel and highly specific NOX inhibitors will provide opportunities to develop NOX inhibitors for treatment of fibrotic pathologies.
No takes yet. Share an insight, caveat, or question.
Bernard et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: